Results from a Real-World Multicenter Analysis of 482 Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib: A Look at Racial Differences

By sjmartinez • September 21, 2023

Barrientos JC, Ayed AO, Cha A, Du S, Fang B, Hall R, Marks SM, Peng E, Rhodes JM, Ryan K, Winters SB, Yeung PL, Hou JZ. Results from a Real-World Multicenter Analysis of 482 Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib: A Look at Racial Differences. Target Oncol. 2023 Sep 20. doi: 10.1007/s11523-023-00988-0. Epub ahead of print. PMID: 37728835.

Tags: General Internal Medicine, Publications, Resident

Sequencing of anti-CD19 therapies in the management of diffuse large B-cell lymphoma

Lownik J, Boiarsky J, Birhiray R, Merchant A, Mead M. Sequencing of anti-CD19 therapies in the management of diffuse large B-cell lymphoma. Clin Cancer Res.[...]

Outpatient hospitalist-run procedure service bridges the gap in oncology care

Ghanem G, Tsai HHC, Durant C, Feigenbaum GS, Glaeser AM. Outpatient hospitalist-run procedure service bridges the gap in oncology care. Transfus Apher Sci. 2024 Apr[...]

Statewide Survey of Primary Care and Subspecialty Providers on Hepatocellular Carcinoma Risk-Stratification and Surveillance Practices

Moon AM, Swier RM, Lane LM, Barritt AS 4th, Sanoff HK, Olshan AF, Wheeler SB, Ioannou GN, Kim NJ, Hagan S, Vutien P, Benefield T,[...]